Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (NASDAQ: PODD) recently received a number of ratings updates from brokerages and research firms: 5/18/2023 – Insulet is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/8/2023 – Insulet had its price target raised by analysts at Barclays PLC from $292.00 to $329.00. 5/5/2023 – Insulet had its […]
William Blair Investment Management LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 40.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 301,601 shares of the medical instruments supplier’s stock after selling 200,951 shares during the quarter. William […]
Motley Fool Asset Management LLC lessened its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 7.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,261 shares of the medical instruments supplier’s stock after selling 103 shares during the quarter. Motley […]
Insulet (NASDAQ:PODD – Get Rating) had its price objective upped by Barclays from $292.00 to $329.00 in a research report report published on Monday morning, The Fly reports. Several other research firms have also recently weighed in on PODD. Raymond James increased their price target on shares of Insulet from $320.00 to $334.00 and gave […]
Washington Trust Advisors Inc. reduced its stake in Insulet Co. (NASDAQ:PODD – Get Rating) by 61.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 101 shares of the medical instruments supplier’s stock after selling 159 shares during the quarter. Washington Trust Advisors Inc.’s holdings […]